Stock Events

Stock Events

Icon 

R$57.10
72
-R$0.05-0.09%Tuesday 17:28

Statistics

Day High
57.1
Day Low
57.1
52W High
59.16
52W Low
31.26
Volume
0
Avg. Volume
65
Mkt Cap
4.28B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Oct 27Expected
Q3 2025
Q2 2026
Q3 2026
13.05
14.66
16.27
17.87
Expected EPS
14.000606186699999
Actual EPS
14.231798

Financials

2.82%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
45.3BRevenue
1.28BNet Income

Analyst Ratings

$380.32Average Price Target
The highest estimate is ⁦481.54⁩.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
58%
Hold
33%
Sell
8%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ICLR34.SA. It's not an investment recommendation.
Microsoft
21
MSFT
Alphabet
20
GOOGL
Amazon
18
AMZN
PepsiCo
17
PEP

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap44.06B
IQVIA provides advanced analytics, technology solutions, and contract research services, making it a direct competitor in pharmaceutical development and healthcare data.
Charles River Laboratories International
CRL
Mkt Cap17.16B
Charles River Laboratories offers a variety of preclinical and clinical laboratory services, competing with ICON in drug development support.
Medpace
MEDP
Mkt Cap18.24B
Medpace is a full-service clinical contract research organization (CRO), offering a similar range of services as ICON, making it a competitor.

About

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Show More
CEO
Barry Balfe
Employees
40100
Country
Ireland
ISIN
BRICLRBDR009

Listings

XETRA
DE
IJF.XETRA
MX
MX
ICLRN.MX
STU
DE
IJF.STU
MU
DE
IJF.MU

0 Comments

Share your thoughts

FAQs

What is Icon stock price today?▼
The current price of ICLR34.SA is R$57.10 BRL — it has decreased by -0.09% in the past 24 hours. Watch Icon stock price performance more closely on the chart.
What is Icon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Sao Paolo Exchange exchange Icon stocks are traded under the ticker ICLR34.SA.
What is Icon market cap?▼
Today Icon has the market capitalization of 4.28B
When is the next Icon earnings date?▼
Icon is going to release the next earnings report on February 24, 2027.
What were Icon earnings last quarter?▼
ICLR34.SA earnings for the last quarter are 14.23 BRL per share, whereas the estimation was 14 BRL resulting in a +1.65% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Icon revenue for the last year?▼
Icon revenue for the last year amounts to 45.3B BRL.
What is Icon net income for the last year?▼
ICLR34.SA net income for the last year is 1.28B BRL.
How many employees does Icon have?▼
As of November 7, 2026, the company has 40,100 employees.
In which sector is Icon located?▼
Icon operates in the Health & Wellness sector.
When did Icon complete a stock split?▼
Icon has not had any recent stock splits.
Where is Icon headquartered?▼
Icon is headquartered in Dublin, Ireland.